Literature DB >> 10190827

The exercise test in Andersen syndrome.

J S Katz1, G I Wolfe, S Iannaccone, W W Bryan, R J Barohn.   

Abstract

BACKGROUND: Andersen syndrome is a rare form of periodic paralysis (PP) associated with dysmorphic features and potentially fatal cardiac dysrhythmias. To date, no electrodiagnostic abnormalities have been reported that can be used to confirm the presence of PP in this condition.
OBJECTIVES: To determine if the exercise test could be used to confirm the diagnosis of PP in Andersen syndrome. To evaluate the exercise test as a means to assess neuromuscular status during treatment.
METHODS: We performed the exercise test on 2 patients with Andersen syndrome. In 1 patient, we used a modified version of the test to document responsiveness to treatment with tocainide.
RESULTS: Studies in both patients demonstrated a progressive decline in the compound muscle action potential amplitude after exercise that was characteristic of the phenomenon seen in other forms of PP. In 1 patient, improvement in interattack strength and a reduction in the number of attacks of weakness correlated with improvement in the test results.
CONCLUSIONS: Our cases demonstrate that the exercise test can confirm the diagnosis of PP in Andersen syndrome. A modified version of exercise testing may also be considered as an objective method for documenting treatment responses in PP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10190827     DOI: 10.1001/archneur.56.3.352

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies.

Authors:  S Veronica Tan; Emma Matthews; Melissa Barber; James A Burge; Sanjeev Rajakulendran; Doreen Fialho; Richa Sud; Andrea Haworth; Martin Koltzenburg; Michael G Hanna
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

Review 2.  Andersen syndrome: the newest variant of the hereditary-familial long QT syndrome.

Authors:  Andrés Ricardo Pérez Riera; Celso Ferreira; Sérgio J Dubner; Edgardo Schapachnik
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

Review 3.  Management and treatment of Andersen-Tawil syndrome (ATS).

Authors:  Valeria Sansone; Rabi Tawil
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

4.  Concomitant presentation of Anderson-Tawil syndrome and myasthenia gravis in an adult patient: A case report.

Authors:  Rui Fan; Ruirui Ji; Wenxin Zou; Guoliang Wang; Hu Wang; Daniel James Penney; Jin Jun Luo; Yuxin Fan
Journal:  Exp Ther Med       Date:  2016-09-06       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.